中国实用外科杂志2026，Vol.46Issue(1)：6-10,5.DOI:10.19538/j.cjps.issn1005-2208.2026.01.02
数智化助力肝癌诊治进展及未来研究方向
Advances and future research directions in digital and intelligent technologies for hepatocellular carcinoma diagnosis and treatment
摘要
Abstract
Hepatocellular carcinoma(HCC)exhibits an insidious onset,high surgical risks,poor clinical prognosis,and significant heterogeneity,posing substantial challenges to conventional diagnostic and therapeutic approaches.With the rapid advancement of digital and intelligent technologies,data-driven and artificial intelligence(AI)-based intelligent diagnostic and therapeutic methods are progressively transforming the entire"diagnosis-treatment-management"continuum of HCC.In diagnostics,machine learning(ML)and deep learning(DL)applied to radiomics,pathomics,and the discovery of novel biomarkers have significantly enhanced early screening for HCC.In treatment,predictive models based on multimodal data support personalized therapeutic decision-making,while AI-integrated three-dimensional visualization,virtual surgical planning,and intraoperative intelligent navigation systems optimize surgical strategies and improve operational safety.In terms of prognosis management,AI technologies enable dynamic postoperative efficacy monitoring,recurrence risk stratification,and facilitate the development of personalized follow-up strategies.关键词
人工智能/肝细胞癌/诊断/治疗/预后Key words
artificial intelligence/hepatocellular carcinoma/diagnosis/treatment/management分类
医药卫生引用本文复制引用
蔡秀军,杨瑾..数智化助力肝癌诊治进展及未来研究方向[J].中国实用外科杂志,2026,46(1):6-10,5.基金项目
National Natural Science Foundation of China(General Program,No.82472742,No.82473007) （General Program,No.82472742,No.82473007）
Ministry of Education Industry-University Cooperation Collaborative Education Program—First Batch of 2024 Approved Projects(No.231104794101356). 国家自然科学基金面上项目(No.82472742,No.82473007) （No.231104794101356）
教育部产学合作协同育人项目2024年第一批次立项项目(No.231104794101356) （No.231104794101356）
